Skip to main content

Advertisement

SpringerLink
Log in

Stem Cell Therapy for Myocardial Infarction 2001–2013 Revisited

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Stem cell therapy for ischemic heart disease was an emerging concept in the early 2000s. First hopes were largely overshadowed by rather inconsistent results in human trials conducted in the middle of the decade. We aimed at investigating how the field of stem cell research expanded worldwide over the years using scientometric methods. We performed a PubMed inquiry and screened a total of 2609 publications dealing with stem cell therapy for myocardial infarction in the years 2001–2013. Density equalizing maps were used to visualize important centres of stem cell research worldwide. This systematic bibliometric study revealed an increasing research interest in the field of stem cell research in the context of ischemic heart disease over the last decade. Though some of the large human trials failed to show significant effects of stem cell therapy, especially basic science represents an ever growing field that evolved promising new concepts over the last couple of years. The scientific principle of protective paracrine mediators released from transplanted stem cells seems to bear great potential for future cell-free therapeutic use. However, further mechanistic insights are needed before transition from bench to bedside should be attempted, taking the lessons learned from previous studies into account.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Velagaleti, R. S., Pencina, M. J., Murabito, J. M., Wang, T. J., Parikh, N. I., et al. (2008). Long-term trends in the incidence of heart failure after myocardial infarction. Circulation, 118, 2057–2062.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Penn, M. S., Francis, G. S., Ellis, S. G., Young, J. B., McCarthy, P. M., et al. (2002). Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis, 45, 21–32.

    Article  PubMed  Google Scholar 

  3. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.

    Article  CAS  PubMed  Google Scholar 

  4. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med, 355, 1210–1221.

    Article  CAS  PubMed  Google Scholar 

  5. Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med, 355, 1222–1232.

    Article  CAS  PubMed  Google Scholar 

  6. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106, 3009–3017.

    Article  PubMed  Google Scholar 

  7. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364, 141–148.

    Article  PubMed  Google Scholar 

  8. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med, 355, 1199–1209.

    Article  CAS  PubMed  Google Scholar 

  9. Leri, A., & Anversa, P. (2013). Stem cells: bone-marrow-derived cells and heart failure--the debate goes on. Nat Rev Cardiol, 10, 372–373.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Meyer, G. P., Wollert, K. C., Lotz, J., Pirr, J., Rager, U., et al. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J, 30, 2978–2984.

    Article  PubMed  Google Scholar 

  11. Nowbar, A. N., Howard, J. P., Finegold, J. A., Asaria, P., & Francis, D. P. (2014). 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol, 174, 293–298.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Schoffel, N., Vitzhum, K., Mache, S., Scutaru, C., Groneberg, D. A., et al. (2010). Critical analysis of publication procedures and evaluation regarding ankylosing spondylitis by density-equalizing mapping and scientometeric methods. Scand J Rheumatol, 39, 430–432.

    Article  CAS  PubMed  Google Scholar 

  13. Vitzthum, K., Mache, S., Quarcoo, D., Scutaru, C., Groneberg, D. A., et al. (2009). Scoliosis: density-equalizing mapping and scientometric analysis. Scoliosis, 4, 15.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Borger, J. A., Neye, N., Scutaru, C., Kreiter, C., Puk, C., et al. (2008). Models of asthma: density-equalizing mapping and output benchmarking. J Occup Med Toxicol, 3(Suppl 1), S7.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Addicks, J. P., Uibel, S., Jensen, A. M., Bundschuh, M., Klingelhoefer, D., et al. (2014). MRSA: a density-equalizing mapping analysis of the global research architecture. Int J Environ Res Public Health, 11, 10215–10225.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Fricke, R., Uibel, S., Klingelhoefer, D., & Groneberg, D. A. (2013). Influenza: a scientometric and density-equalizing analysis. BMC Infect Dis, 13, 454.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Gastner, M. T., & Newman, M. E. (2004). From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci U S A, 101, 7499–7504.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Lovett, D. A., Poots, A. J., Clements, J. T., Green, S. A., Samarasundera, E., et al. (2014). Using geographical information systems and cartograms as a health service quality improvement tool. Spat Spatiotemporal Epidemiol, 10, 67–74.

    Article  PubMed  Google Scholar 

  19. Assmus, B., Leistner, D. M., Schachinger, V., Erbs, S., Elsasser, A., et al. (2014). Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. Eur Heart J, 35, 1275–1283.

    Article  CAS  PubMed  Google Scholar 

  20. Gyongyosi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., et al. (2015). Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res, 116, 1346–1360.

    Article  PubMed  Google Scholar 

  21. Seeger, F. H., Tonn, T., Krzossok, N., Zeiher, A. M., & Dimmeler, S. (2007). Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J, 28, 766–772.

    Article  PubMed  Google Scholar 

  22. Korf-Klingebiel, M., Kempf, T., Sauer, T., Brinkmann, E., Fischer, P., et al. (2008). Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J, 29, 2851–2858.

    Article  PubMed  Google Scholar 

  23. Jung, C., Fischer, N., Fritzenwanger, M., Thude, H., Ferrari, M., et al. (2009). Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol, 98, 179–188.

    Article  CAS  PubMed  Google Scholar 

  24. Cohen, K. S., Cheng, S., Larson, M. G., Cupples, L. A., McCabe, E. L., et al. (2013). Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood, 121, e50–56.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. du Pre, B. C., Doevendans, P. A., & van Laake, L. W. (2013). Stem cells for cardiac repair: an introduction. J Geriatr Cardiol, 10, 186–197.

    PubMed Central  PubMed  Google Scholar 

  26. Boyle, A. J., Schulman, S. P., Hare, J. M., & Oettgen, P. (2006). Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation, 114, 339–352.

    Article  PubMed  Google Scholar 

  27. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med, 7, 430–436.

    Article  CAS  PubMed  Google Scholar 

  28. Lichtenauer, M., Mildner, M., Baumgartner, A., Hasun, M., Werba, G., et al. (2011). Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol, 106, 645–655.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Zeng, B., Ren, X., Lin, G., Zhu, C., Chen, H., et al. (2008). Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. Cell Biol Int, 32, 1256–1264.

    Article  CAS  PubMed  Google Scholar 

  30. Kofidis, T., de Bruin, J. L., Yamane, T., Tanaka, M., Lebl, D. R., et al. (2005). Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation, 111, 2486–2493.

    Article  CAS  PubMed  Google Scholar 

  31. Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., et al. (2014). Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res, 103, 530–541.

    Article  CAS  PubMed  Google Scholar 

  32. Ibrahim, A. G., Cheng, K., & Marban, E. (2014). Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports, 2, 606–619.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S., Choo, A., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res, 4, 214–222.

    Article  CAS  PubMed  Google Scholar 

  34. Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med, 11, 367–368.

    Article  CAS  PubMed  Google Scholar 

  35. Perez-Ilzarbe, M., Agbulut, O., Pelacho, B., Ciorba, C., San Jose-Eneriz, E., et al. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail, 10, 1065–1072.

    Article  CAS  PubMed  Google Scholar 

  36. Dai, W., Hale, S. L., & Kloner, R. A. (2007). Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med, 2, 63–68.

    Article  PubMed  Google Scholar 

  37. Niagara, M. I., Haider, H., Jiang, S., & Ashraf, M. (2007). Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res, 100, 545–555.

    Article  CAS  PubMed  Google Scholar 

  38. Tang, Y. L., Zhao, Q., Qin, X., Shen, L., Cheng, L., et al. (2005). Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg, 80, 229–236. discussion 236–227.

    Article  PubMed  Google Scholar 

  39. Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res, 98, 1414–1421.

    Article  CAS  PubMed  Google Scholar 

  40. Lichtenauer, M., Mildner, M., Hoetzenecker, K., Zimmermann, M., Podesser, B. K., et al. (2011). Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol, 106, 1283–1297.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Vicencio, J. M., Yellon, D. M., Sivaraman, V., Das, D., Boi-Doku, C., et al. (2015). Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol, 65, 1525–1536.

    Article  CAS  PubMed  Google Scholar 

  42. Maltais, S., Tremblay, J. P., Perrault, L. P., & Ly, H. Q. (2010). The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res, 3, 652–662.

    Article  PubMed  Google Scholar 

  43. Pavo, N., Charwat, S., Nyolczas, N., Jakab, A., Murlasits, Z., et al. (2014). Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol, 75C, 12–24.

    Article  Google Scholar 

Download references

Acknowledgments

We want to thank Kristen Kopp for her great support editing the manuscript.

Conflict of Interest

The authors declare that there is no conflict of interests regarding the publication of this paper.

Funding

The authors received no specific funding for this work. The authors declare that there is no conflict of interests regarding the publication of this paper.

Author information

Authors and Affiliations

  1. University Clinic of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Müllner Hauptstraße 48, 5020, Salzburg, Austria

    Christoph Edlinger, Bernhard Wernly, Alexandra Anker, Katja Ruzicka, Uta C. Hoppe & Michael Lichtenauer

  2. University Clinic of Cardio-Thoracic Surgery, Paracelsus Medical University of Salzburg, Salzburg, Austria

    Catharina Schreiber

  3. Universitätsherzzentrum Thüringen, Clinic of Internal Medicine I, Department of Cardiology, Friedrich Schiller University Jena, Jena, Germany

    Christian Jung

Authors
  1. Christoph Edlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catharina Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernhard Wernly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandra Anker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katja Ruzicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Uta C. Hoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Michael Lichtenauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Lichtenauer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edlinger, C., Schreiber, C., Wernly, B. et al. Stem Cell Therapy for Myocardial Infarction 2001–2013 Revisited. Stem Cell Rev and Rep 11, 743–751 (2015). https://doi.org/10.1007/s12015-015-9602-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-015-9602-z

Keywords

Search

Navigation